| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c378e3dfc1120eafe692ec2941174f08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1df5c49bcb57a9b362384d894ce988ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_847cd3bb3c091c1663bfee25b8db3b43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6718e7827a7bd08068671676a4f4e2c4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-726 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-02 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B40-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B50-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C30B30-06 |
| filingDate |
2006-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebeaf0049da3720c8d2e2f9713f472bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_473d467590b2a72bc4bd0ac2f16266cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67b88a4bb1f11a7adf98981bb6f55656 |
| publicationDate |
2013-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8426345-B2 |
| titleOfInvention |
Method of drug design |
| abstract |
The invention provides a method of identifying biologically active compounds comprising: (a) designing a first library of compounds of formula (1) to scan molecular diversity wherein each compound of the library has at least two pharmacophoric groups R1 to R5 as defined below and wherein compound of the library has same number of pharmacophoric groups; (b) assaying the first library of compounds in one or more biological assay(s); and (c) designing a second library wherein each compound of the second library contains one or more additional pharmacophoric group with respect to the first library; such that the/each component of the first and second library is a compound of formula (1). |
| priorityDate |
2005-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |